Branch KRH, Probstfield JL, Bosch J, Bhatt DL, et al. Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial. Am Heart J 2023 Jan 13:S0002-8703(23)00015-7. doi: 10.1016/j.ahj.2023.
PMID: 36646196